EyePoint, Inc. - EYPT

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Mar 26, 2026 SCHEDULE 13G/A The Vanguard Group 0.0% 0 View
Feb 24, 2026 SCHEDULE 13G Paradigm BioCapital Advisors LP 5.1% 4,192,261 View
Feb 24, 2026 SCHEDULE 13G Paradigm BioCapital Advisors GP LLC 5.1% 4,192,261 View
Feb 24, 2026 SCHEDULE 13G Senai Asefaw, M.D. 5.1% 4,192,261 View
Feb 24, 2026 SCHEDULE 13G Paradigm BioCapital International Fund Ltd. 4.5% 3,694,542 View
Feb 17, 2026 SCHEDULE 13G/A TCG Crossover GP II, LLC 4.3% 3,572,335 View
Feb 17, 2026 SCHEDULE 13G/A TCG Crossover Fund II, L.P. 4.3% 3,572,335 View
Feb 17, 2026 SCHEDULE 13G/A Chen Yu 4.3% 3,572,335 View
Feb 12, 2026 SCHEDULE 13G/A Adage Capital Management, L.P. 5.68% 4,700,000 View
Feb 12, 2026 SCHEDULE 13G/A Robert Atchinson 5.68% 4,700,000 View
Feb 12, 2026 SCHEDULE 13G/A Phillip Gross 5.68% 4,700,000 View
Dec 08, 2025 SCHEDULE 13G/A Cormorant Asset Management, LP 9.98% 8,265,000 View
Dec 08, 2025 SCHEDULE 13G/A Chen Bihua 9.98% 8,265,000 View
Nov 13, 2025 SCHEDULE 13G/A Adage Capital Management, L.P. 8.07% 5,559,782 View
Nov 13, 2025 SCHEDULE 13G/A Robert Atchinson 8.07% 5,559,782 View
Nov 13, 2025 SCHEDULE 13G/A Phillip Gross 8.07% 5,559,782 View
Oct 17, 2025 SCHEDULE 13G/A BlackRock, Inc. 6.5% 4,485,402 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.